China Resources Double-Crane Pharmaceutical Co Ltd (600062) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China.

Total Revenue Chart for China Resources Double-Crane Pharmaceutical Co Ltd

China Resources Double-Crane Pharmaceutical Co Ltd (600062) revenue for FY2025 was CNY 11.0B, a -1.9% change from FY2024. China Resources Double-Crane Pharmaceutical Co Ltd's revenue grew from CNY 156.7M in 1994 to CNY 11.0B in 2025 (6919.2% over 31 years). Earnings per share grew from CNY 0.17 in 2000 to CNY 0.90 in 2021 (430.3%). Revenue compound annual growth rate: 5-year CAGR of 5.3%, 10-year CAGR of 7.9%, 20-year CAGR of 4.5%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.